πŸ‡ΊπŸ‡Έ FDA
Patent

US 9345726

CD117+ cells and uses thereof

granted A61KA61K2035/122A61K35/28

Quick answer

US patent 9345726 (CD117+ cells and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2035/122, A61K35/28, A61K45/06, A61K9/0019